10.07.18|CTechJerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
17.06.18|Dror ReichThe Israel-based cancer immunotherapy company intends to use the proceedings for product development
17.04.18|Lilach BaumerFoamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
04.04.18|Lilach BaumerThe company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014